Neuroblastoma Research and Treatments
Neuroblastoma Research and Treatments is a research topic within Neurology. Science Explorer counts 36k research works in it since 1950. 10.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers represents a comprehensive exploration of neuroblastoma, covering topics such as genetic mutations (including ALK and MYCN), risk classification, staging systems, immunotherapy, and genomic analysis. The research also delves into therapy strategies and prognosis for patients with neuroblastoma.
- Neuroblastoma
- ALK
- Genomic
- MYCN
- Therapy
- Risk Classification
- Immunotherapy
- Genetic Mutations
- Staging System
- Prognosis
- Research works
- 36k fractional, since 1950
- In the world top 10%
- 3.8k per year above
- Top-10% rate
- 10.4% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +2% the tick is no change
- Largest producer
United States
39% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Neuroblastoma Research and Treatments research?
By volume, the United States and China publish the most (1.8k and 807 works in 2022-now).
By volume, 2022-now
- 1
United States 1.8k works
- 2
China 807 works
- 3
India 360 works
- 4
Italy 305 works
- 5
Germany 293 works
- 6
Japan 292 works
- 7
United Kingdom 196 works
- 8
France 172 works
- 9
Spain 146 works
- 10
Canada 139 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Neuroblastoma Research and Treatments research?
By volume in 2022-now, Harvard University publishes the most Neuroblastoma Research and Treatments research, followed by Capital Medical University and National Institutes of Health.
By volume, 2022-now
- 1
Harvard University
United States 76 works
- 2
Capital Medical University
China 58 works
- 3
National Institutes of Health
United States 49 works
- 4
All India Institute of Medical Sciences
India 49 works
- 5
University of Toronto
Canada 46 works
- 6
Memorial Sloan Kettering Cancer Center
United States 44 works
- 7
Mayo Clinic
United States 43 works
- 8
St. Jude Children's Research Hospital
United States 39 works
- 9
Shanghai Jiao Tong University
China 39 works
- 10
The University of Texas MD Anderson Cancer Center
United States 36 works
Who are the leading researchers in Neuroblastoma Research and Treatments?
The most-cited researchers publishing on Neuroblastoma Research and Treatments include Guido Kroemer, Bert Vogelstein and Gad A. Getz.
- 1
Guido Kroemer
France 386k citations
- 2
Bert Vogelstein
United States 373k citations
- 3
Gad A. Getz
United States 364k citations
- 4
Elaine R. Mardis
United States 346k citations
- 5
Hermann Brenner
Germany 343k citations
- 6
Jun Wang
China 340k citations
- 7
Robert A. Weinberg
United States 301k citations
- 8
Richard A. Gibbs
United States 292k citations
- 9
John Q. Trojanowski
United States 286k citations
- 10
Todd R. Golub
United States 283k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Neuroblastoma Research and Treatments research done?
The largest centres of Neuroblastoma Research and Treatments research in 2022-now are Beijing (China), New York (United States), Shanghai (China) and Moscow (Russia). Among places with at least 20 works in it, it is an unusually large share of all research in Memphis, Heidelberg and Genoa.
Largest cities, 2022-now
- 1
Beijing
China 135 works
- 2
New York
United States 100 works
- 3
Shanghai
China 91 works
- 4
Moscow
Russia 78 works
- 5
Boston
United States 77 works
- 6
Houston
United States 74 works
- 7
Philadelphia
United States 73 works
- 8
London
United Kingdom 72 works
- 9
Paris
France 66 works
- 10
Rome
Italy 66 works
Where it is the local speciality
- MemphisUS · 47.0 works16×
- HeidelbergDE · 51.3 works8.5×
- GenoaIT · 24.1 works7.2×
- BethesdaUS · 49.6 works7.0×
Location quotient: how much more of its research is in Neuroblastoma Research and Treatments than the world average.
Where is the best place to study Neuroblastoma Research and Treatments?
Among universities, judged by research, Harvard University, Karolinska Institutet and Lund University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Neuroblastoma Research and Treatments, country by countryIs Neuroblastoma Research and Treatments research growing?
Output in 2022-2025 was 2% higher than in 2018-2021, peaking in 2022. The fastest-growing topics are Neuroblastoma Research and Treatments.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Neuroblastoma Research and Treatments as a percentage of every work published that year, 0.026% in 2024.
Fractional works of Neuroblastoma Research and Treatments over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Neuroblastoma Research and Treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.